Senzo Health Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.8M

  • Investors
  • 21

Senzo Health General Information

Description

Developer of invitro diagnostics technology designed for accurate and accessible testing products. The company's platform utilizes novel technologies to create mobile, point-of-care, and self-testing products and devices with the ability to accurately, quickly, and cost-effectively conduct testing, enabling people by putting healthcare information directly into their hands to improve their quality of life.

Contact Information

Website
www.senzo.com
Formerly Known As
Orphidia
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Primary Office
  • 64 Rochester Place
  • London NW1 9JX
  • England, United Kingdom

Senzo Health Timeline

2020202120222023
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Senzo Health Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 05-Oct-2023 $1.8M 00.00 Completed Pre-Clinical Trials
5. Later Stage VC 12-Dec-2022 00.00 00.000 0000 Completed Pre-Clinical Trials
4. Seed Round 26-Feb-2018 00.00 00.000 00.00 Completed Product Development
3. Accelerator/Incubator 07-Aug-2017 00.000 Completed Product Development
2. Seed Round 16-Mar-2016 $1.27M $1.33M 00.000 Completed Product Development
1. Accelerator/Incubator 15-May-2015 $50K $50K 00.000 Completed Product Development
To view Senzo Health’s complete valuation and funding history, request access »

Senzo Health Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed-2 0,000,000 00.000000 00.00 00.00 00.00 00.000
Seed-3 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 2,618,610 $0.000100 $0.41 $0.41 1x $0.41 14.05%
To view Senzo Health’s complete cap table history, request access »

Senzo Health Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of invitro diagnostics technology designed for accurate and accessible testing products. The company's platfor
Other Devices and Supplies
London, United Kingdom
19 As of 2023
00.00
000000000 00.00

000000

aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugia
00000 0000000 000 00
San Diego, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

000000

0000000000 000000000
Emeryville, CA
000 As of 0000
00000
00.00 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Senzo Health Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genalyte Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
000000 000000 Formerly VC-backed Emeryville, CA 000 00000 000000&0
00000000000 Corporation San Diego, CA 0000 00.00 000000000 00.00
00000000 Formerly VC-backed London, United Kingdom 0000 00.000 000000000 00.000
000000 00000000000 Failed Transaction (M&A) Lake Forest, IL 000000&0
You’re viewing 5 of 7 competitors. Get the full list »

Senzo Health Patents

  • 17

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Senzo Health Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230062903-A1 High sensitivity analyte network detection flow assays and related methods Pending 11-Aug-2021 0000000000
US-20230194518-A1 High sensitivity analyte network detection flow assays and related methods Pending 11-Aug-2021 0000000000
US-20180203003-A1 Linker molecule for treating a substrate surface Inactive 17-Jul-2015 0000000000 0
US-20210231648-A1 Linker molecule for treating a substrate surface Pending 17-Jul-2015 0000000000 0
GB-201509369-D0 Method and system for controlling dynamic range of assay quantification for analyte detection Inactive 31-May-2015
To view Senzo Health’s complete patent history, request access »

Senzo Health Executive Team (10)

Name Title Board Seat Contact Info
Aron Rachamim Ph.D Co-Founder, Chief Operating Officer, President & Board Member
Youba Diakite Ph.D Chief Technology Officer & Board Member
Alex Mohacs Business Development Executive
Jared Slosberg JD Co-Founder & Executive Chairman
Jeremy Stackawitz Chief Executive Officer & Board Member
You’re viewing 5 of 10 executive team members. Get the full list »

Senzo Health Board Members (5)

Name Representing Role Since
Aron Rachamim Ph.D Senzo Health Co-Founder, Chief Operating Officer, President & Board Member 000 0000
Jacob Baby Self Board Member 000 0000
Jared Slosberg JD Senzo Health Co-Founder & Executive Chairman 000 0000
Jeremy Stackawitz Self Chief Executive Officer & Board Member 000 0000
Youba Diakite Ph.D Senzo Health Chief Technology Officer & Board Member 000 0000
To view Senzo Health’s complete board members history, request access »

Senzo Health Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Senzo Health Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ramp Health PE-Backed Company Minority 000 0000 000000 0
Advisors.Fund Venture Capital Minority 000 0000 000000 0
Ataria Venture Capital Minority 000 0000 000000 0
BioAdvance Venture Capital Minority 000 0000 000000 0
Brandon Calder Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 21 investors. Get the full list »

Ready to get started?

Request a free trial